Haematology News/Publications

2010

• Gupta M, Ashok Kumar J, Sitaram U, Neeraj S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A, George B, Chandy M Srivastava A, Srivastava VM. The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases Cancer Genet Cytogenet. 2010 Dec;203:297-302
• George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia: a single-center analysis of 100 patients. Pediatr Hematol Oncol. 2010;27:122 131.
• Viswabandya A, Baidya S, Nair SC, Lakshmi KM, Mathews V, George B, Chandy M Srivastava A. Clinical manifestations of combined factor V and VIII deficiency: a series of 37 cases from a single center in India. Am J Hematol 2010;85:538-539.
• Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in  laboratory haemostasis. Haemophilia 2010 Jul;16 Suppl 5:93-9.
• Nair SC, Dargaud Y, Chitlur M, Srivastava A. Tests of global  haemostasis and their applications in bleeding disorders. Haemophilia. 2010;16 Suppl 5:85-92
• Rajasekar R, Lakshmi KM, George B, Viswabandya A, Thirugnanam R, Abraham A  Chandy M, Srivastava A, Mathews V. Dendritic cell count in the graft predicts relapse in patients with hematological malignancies undergoing a HLA-matched  related allogeneic peripheral blood stem cell transplant. Biol Blood Marrow   Transplant. 2010 16: 854-60.
• George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia - A single-center analysis of 100 patients. Pediatr Hematol Oncol. 2010Mar;27(2):122-31
• Stonebraker JS, Brooker M, Amand RE, Farrugia A, Srivastava A. A study of reported factor VIII use around the world. Haemophilia. 2010 Jan;16(1):33-46
• Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya P, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M. Single Agent Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: Long Term Follow Up Data. J Clin Oncol. 2010 Aug 20;28:3866-3871.
• Desire S, Balasubramanian P, Bajel A, George B, Viswabandya A, Mathews V, Srivastava A, Chandy C. Frequency of TPMT alleles in Indian patients with Acute Lymphatic leukemia and effect on the dose of 6-mercaptopurine. Med Oncol 2010 Dec;27(4):1046-1049
• Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, and  Srivastava A. Optimized AAV-protein phosphatase 5 helper-viruses for efficient transduction by single-stranded AAV vectors: Therapeutic expression of Factor IX at reduced vector doses.  Hum Gene Therapy, 2010; 21:271-283
• Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, Min SH, Chiodo V, Neeley AW, Govindasamy L, Bennett A, Agbandje-McKenna M, Zhong L, Li B, Jayandharan GR, Srivastava A, Lewin AS, Hauswirth WW. Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina. Mol. Therapy, in press, 2010
• Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia, 2010; Suppl 5:93-99.
• Markusic DM, Herzog RW, Aslanidi GV, Hoffman BE, Li B, Li M, Jayandharan GR, Ling C, Zolotukhin I, Ma W, Zolotukhin S, Srivastava A, Zhong L. High-efficiency transduction and correction of murine haemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.Mol Therapy, 2010; 18:2048-2056.
• Ling C, Lu Y, Kelsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, Agbandje-McKenna M, Zhong L, Srivastava A. Human Hepatocyte Growth Factor Receptor is a Cellular Co-Receptor for AAV3. Human Gene Therapy, 2010; 21:1741-1747
• Qiao C, Zhang W, Yuan Z, Shin JH, Li J, Jayandharan GR, Zhong L, Srivastava A, Xiao X, Duan D. AAV6 capsid tyrosine to phenylalanine mutations improve gene transfer to skeletal muscle. Hum Gene Therapy, 2010; 21:1343-1348.
• Li M, Jayandharan GR, Li B, Chen L, Ma W, Srivastava A, Zhong L. High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy. Hum Gene Therapy, 2010; 21(11):1527-1543.

<< Back to Archives